NYSEArca - Delayed Quote USD

Harbor Multi-Asset Explorer ETF (MAPP)

21.43 +0.17 (+0.79%)
At close: April 17 at 3:59 PM EDT
Key Events
Loading Chart for MAPP
DELL
  • Previous Close 20.86
  • Open 21.23
  • Bid 21.40 x 900
  • Ask 21.47 x 900
  • Day's Range 21.31 - 21.31
  • 52 Week Range 18.90 - 21.81
  • Volume 20
  • Avg. Volume 207
  • Net Assets 3.8M
  • NAV 21.40
  • PE Ratio (TTM) --
  • Yield --
  • YTD Daily Total Return 5.18%
  • Beta (5Y Monthly) 0.00
  • Expense Ratio (net) 0.92%

To seek to achieve the fund’s investment objective, Harbor Capital Advisors Inc., the fund’s investment adviser (the “advisor”), allocates the fund’s assets among various asset classes and market sectors based on its assessment of global economic and market conditions, primarily through investments in a diversified portfolio of exchange-traded funds, including other funds managed by the advisor.

Harbor

Fund Family

Global Allocation

Fund Category

3.8M

Net Assets

2023-09-13

Inception Date

Performance Overview: MAPP

Trailing returns as of 4/26/2024. Category is Global Allocation.

YTD Return

MAPP
5.18%
Category
4.38%
 

1-Year Return

MAPP
0.00%
Category
11.51%
 

3-Year Return

MAPP
0.00%
Category
2.78%
 

People Also Watch

Holdings: MAPP

Top 10 Holdings (82.65% of Total Assets)

SymbolCompany% Assets
IVV
iShares Core S&P 500 ETF 28.07%
IAUF
iShares Gold Strategy ETF 9.99%
VGK
Vanguard FTSE Europe ETF 7.50%
EWJ
iShares MSCI Japan ETF 6.63%
XLC
Communication Services Select Sector SPDR Fund 6.31%
EFA
iShares MSCI EAFE ETF 5.86%
EEM
iShares MSCI Emerging Markets ETF 4.90%
IEF
iShares 7-10 Year Treasury Bond ETF 4.74%
HYG
iShares iBoxx $ High Yield Corporate Bond ETF 4.44%
XLK
Technology Select Sector SPDR Fund 4.21%

Sector Weightings

SectorMAPP
Technology   25.60%
Industrials   8.93%
Energy   8.54%
Healthcare   8.41%
Utilities   1.72%
Real Estate   1.65%

Related ETF News

Research Reports: MAPP

  • IRWD: Raising target price to $9.00

    IRONWOOD PHARMACEUTICALS INC has an Investment Rating of HOLD; a target price of $9.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of High.

    Rating
    Price Target
     
  • JAZZ: Raising target price to $115.00

    JAZZ PHARMACEUTICALS PLC has an Investment Rating of HOLD; a target price of $115.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Price Target
     
  • JAZZ: Lowering target price to $114.00

    JAZZ PHARMACEUTICALS PLC has an Investment Rating of HOLD; a target price of $114.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Price Target
     
  • IRWD: Lowering target price to $8.00

    IRONWOOD PHARMACEUTICALS INC has an Investment Rating of HOLD; a target price of $8.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of High.

    Rating
    Price Target
     

Related Tickers